| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| TCF7L2 |
Q9NQB0
|
transcription factor 7 like 2
|
|
1.00 |
0.485 |
0.846 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| FOXP1 |
Q9H334
|
forkhead box P1
|
|
1.00 |
0.460 |
0.808 |
| GLIS3 |
Q8NEA6
|
GLIS family zinc finger 3
|
|
5.6E-08 |
0.590 |
0.654 |
| HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| CSMD1 |
Q96PZ7
|
CUB and Sushi multiple domains 1
|
|
1.00 |
0.610 |
0.500 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| CADM2 |
Q8N3J6
|
cell adhesion molecule 2
|
|
0.89 |
0.670 |
0.538 |
| TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
| SMG6 |
Q86US8
|
SMG6 nonsense mediated mRNA decay factor
|
|
0.98 |
0.751 |
0.308 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
| MAD1L1 |
Q9Y6D9
|
mitotic arrest deficient 1 like 1
|
|
6.8E-16 |
0.570 |
0.731 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| ZNF365 |
Q70YC4 Q70YC5
|
zinc finger protein 365
|
|
4.7E-04 |
0.641 |
0.654 |
| ANK3 |
Q12955
|
ankyrin 3
|
|
1.00 |
0.578 |
0.654 |
| LRP1B |
Q9NZR2
|
LDL receptor related protein 1B
|
|
2.5E-06 |
0.626 |
0.615 |